reviewNature Reviews Drug DiscoveryAug 1, 2012Closed access

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

CACharles A. DinarelloASAnna SimonJWJos W.M. van der Meer

University of Colorado Denver · Radboud University Nijmegen · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,749
total citations
FWCI
45.68
Percentile
100%
References
225
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Anakinra
  • Canakinumab
  • Medicine
  • Immunology
  • Monoclonal antibody
  • Inflammation
  • Interleukin 1 receptor antagonist
  • Receptor antagonist
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.